Related Experiment Video
Updated: Jun 11, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis
Benedikt Bernhard1, Martin E Marxer2, Jan C Zurkirchen2
1Department of Cardiology, University Hospital Bern, Bern, Switzerland; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Insights
The European Society of Cardiology (ESC) criteria are effective for diagnosing myocarditis and predicting patient outcomes. Updated Lake-Louise criteria (LLC) also show prognostic value, highlighting the importance of clinical and cardiac MRI findings.
Area of Science:
- Cardiology
- Medical Diagnostics
- Cardiac Imaging
Background:
- Current diagnostic criteria for myocarditis vary among major cardiology societies.
- The prognostic implications of these differing criteria have not been previously compared.
Purpose of the Study:
- To compare the diagnostic and prognostic value of European Society of Cardiology (ESC) criteria, updated Lake-Louise criteria (LLC), American Heart Association (AHA) probable acute myocarditis (pAM) criteria, and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM).
Main Methods:
- A cohort of 1,050 patients with suspected myocarditis and available cardiac magnetic resonance (CMR) data were analyzed.
- Patients without alternative diagnoses were assessed for adherence to various myocarditis diagnostic criteria.
- The association between diagnostic criteria and adverse composite outcomes (heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death) was evaluated.
Main Results:
- Most patients (89.3%) met ESC criteria, while fewer met LLC (28.5%), pAM (33.9%), AM (20.6%), or CM (7.3%).
- Adverse events occurred in 15.3% of patients over a median follow-up of 3.4 years.
- ESC criteria and LLC demonstrated the strongest independent and incremental prognostic value for adverse outcomes, with LLC showing the highest event rates (6.6%).
Conclusions:
- ESC criteria identify a larger proportion of myocarditis patients in a real-world setting compared to LLC.
- Both ESC and LLC criteria possess significant independent prognostic value.
- Integrating clinical assessment (ESC criteria) with CMR findings (LLC) is crucial for accurate myocarditis diagnosis and risk stratification.
Background:
The European Society of Cardiology (ESC), the American College of Cardiology, the American Heart Association, and expert consensus documents provide different diagnostic criteria for myocarditis. Their overlap and prognostic value have never been compared.
Objectives:
This study aims to assess and compare the predictive value of ESC criteria for clinically suspected myocarditis, updated Lake-Louise criteria (LLC), American Heart Association criteria for probable acute myocarditis (pAM), and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM).
Methods:
Patients with a clinical suspicion of myocarditis referred for cardiac magnetic resonance were enrolled at 2 centers. Those with any prior cardiomyopathy were excluded. The association of composite outcome events (heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death) with ESC diagnostic criteria, LLC, pAM, AM, and CM were compared.
Results:
Among 1,557 consecutive patients referred for cardiac magnetic resonance with possible myocarditis, 1,050 (62.6% male; 48.9 ± 16.8 years of age) were without an alternative diagnosis. Of those, 938 (89.3%) met ESC criteria for clinically suspected myocarditis, 299 (28.5%) LLC, and 356 (33.9%), 216 (20.6%), and 77 (7.3%) pAM, AM, and CM, respectively. Adverse events occurred in 161 patients (15.3%) during a median follow-up of 3.4 years. The highest annualized event rates (6.6%) were observed in patients meeting LLC, whereas negative ESC criteria indicated excellent prognosis (0.7% annualized event rate). Among all myocarditis definitions, ESC criteria and LLC were the strongest multivariable outcome predictors and had independent and incremental prognostic value (HRadjusted: 3.87; 95% CI: 1.22-12.2; P = 0.021, and HRadjusted: 2.53; 95% CI: 1.83-3.49; P < 0.001, respectively) when adjusted for clinical characteristics.
Conclusions:
In a real-world cohort of patients with possible myocarditis, diagnosis was reached in most patients using ESC criteria whereas only approximately one-quarter of patients reached a diagnosis with LLC. The independent prognostic value of ESC-criteria and LLC highlights the complementary role of clinical and CMR-based findings in the diagnosis and risk stratification of myocarditis.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Pericarditis II: Clinical features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Myocarditis IV: Nursing Management

